BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions with no assurance regarding timing, size, or terms.
Proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Public Offering Announcement
BioSig Technologies intends to offer shares of common stock through an underwritten public offering, with details subject to market conditions.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion, support working capital, and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
- The completion of the offering is subject to market conditions, and uncertainty remains regarding its timing and terms.
- The Company aims to use the funds raised to enhance its investment policy by purchasing gold bullion and supporting its overall operations.
BioSig Technologies' proposed public offering signifies a strategic move to raise capital for future growth and investment in gold bullion.